Related Experiment Video
Updated: Jan 27, 2026

06:38
Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation
Published on: May 3, 2018
9.0K
A co-delivery platform based on plasmid DNA peptide-surfactant complexes: formation, characterization and release
Diana Costa1, Tânia Albuquerque1, João A Queiroz1
1CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Colloids and Surfaces. B, Biointerfaces
|March 26, 2019
Summary
TAT peptide and surfactants create effective DNA delivery systems. This novel platform enhances therapeutic payload loading and controlled release for biomedical applications.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Nanotechnology
Background:
- Cell-penetrating peptides, like TAT, show promise for intracellular delivery.
- Plasmid DNA (pDNA) delivery faces challenges with particle size and pDNA immobilization.
- Optimizing delivery systems is crucial for advancing therapeutic efficacy.
Purpose of the Study:
- To investigate the pDNA condensation ability of TAT peptide for intracellular delivery.
- To enhance the performance of TAT peptide-based delivery systems using surfactants.
- To evaluate the potential of the developed platform for therapeutic payload delivery and controlled release.
Main Methods:
- Formation of polyplexes using TAT peptide and pDNA at various nitrogen to phosphate (N/P) ratios.
- Incorporation of alkyl trimethyl ammonium bromide (CnTAB) surfactants to further condense pDNA.
- Characterization of polyplex properties, including size, surface charge, and pDNA encapsulation efficiency.
- Assessment of cytotoxicity and drug loading/release kinetics for doxorubicin and paclitaxel.
Main Results:
- TAT peptide alone formed large carriers with low pDNA immobilization.
- Co-condensation with CnTAB surfactants significantly reduced vector size and improved surface charge and pDNA encapsulation.
- Surfactant chain length critically influenced vector characteristics.
- Cytotoxicity of surfactants was substantially reduced upon complexation.
- Controlled/sustained release of pDNA was achievable, tunable by surfactant chain length and N/P ratio.
- Efficient loading of doxorubicin and paclitaxel into the TAT/pDNA/surfactant carriers was demonstrated.
Conclusions:
- TAT peptide/surfactant complexes offer a promising platform for pDNA delivery.
- This system enhances therapeutic payload encapsulation and enables controlled release.
- The tunable nature of the platform supports innovative biomedical system design for clinical translation.
Keywords:
Cationic surfactantsCell penetrating peptidesControlled/sustained releaseDrug/gene co-deliverypDNA compactionpDNA-surfactant complexesMore Related Videos
Related Concept Videos
Formation of Complex Ions
25.9K
A type of Lewis acid-base chemistry involves the formation of a complex ion (or a coordination complex) comprising a central atom, typically a transition metal cation, surrounded by ions or molecules called ligands. These ligands can be neutral molecules like H2O or NH3, or ions such as CN− or OH−. Often, the ligands act as Lewis bases, donating a pair of electrons to the central atom. These types of Lewis acid-base reactions are examples of a broad subdiscipline called coordination...
25.9K
DNA Base Pairing
33.1K
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
33.1K
DNA Base Pairing
32.2K
32.2K
Peptide Bonds
82.6K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.6K
DNA-only Transposons
17.4K
DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
The donor site from where the transposon is excised is either degraded or...
17.4K
From DNA to Protein
22.3K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
22.3K

